These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 32247597

  • 1. Conversion From a Twice-Daily to a Once-Daily Tacrolimus Formulation in Kidney Transplant Recipients.
    Kamińska D, Poznański P, Kuriata-Kordek M, Zielińska D, Mazanowska O, Kościelska-Kasprzak K, Krajewska M.
    Transplant Proc; 2020 Oct; 52(8):2288-2293. PubMed ID: 32247597
    [Abstract] [Full Text] [Related]

  • 2. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E.
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [Abstract] [Full Text] [Related]

  • 3. Trough Level and Tacrolimus Variability of Early Converted Once-Daily Tacrolimus: 1-Year Follow-up Study.
    Sukkha S, Suansanae T, Iamrahong P, Wiwattanathum P.
    Transplant Proc; 2020 Apr; 52(3):775-779. PubMed ID: 32143870
    [Abstract] [Full Text] [Related]

  • 4. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study.
    Sukkha S, Chindavijak B, Montakantikul P, Ingsathit A, Nosoongnoen W, Sumethkul V.
    Int J Clin Pharm; 2017 Dec; 39(6):1298-1303. PubMed ID: 29101615
    [Abstract] [Full Text] [Related]

  • 5. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
    Kolonko A, Chudek J, Wiecek A.
    Transplant Proc; 2011 Oct; 43(8):2950-3. PubMed ID: 21996198
    [Abstract] [Full Text] [Related]

  • 6. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
    Kim SH, Lee SD, Kim YK, Park SJ.
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
    Shuker N, Cadogan M, van Gelder T, Roodnat JI, Kho MM, Weimar W, Hesselink DA.
    Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A, Tinti F, Poli L, Bachetoni A, Umbro I, Nofroni I, Lai Q, Pretagostini R, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [Abstract] [Full Text] [Related]

  • 10. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
    Baccarani U, Velkoski J, Pravisani R, Adani GL, Lorenzin D, Cherchi V, Falzone B, Baraldo M, Risaliti A.
    Transplant Proc; 2019 Nov; 51(9):2971-2973. PubMed ID: 31607620
    [Abstract] [Full Text] [Related]

  • 11. Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.
    Uchida J, Kuwabara N, Machida Y, Iwai T, Naganuma T, Kumada N, Nakatani T.
    Transplant Proc; 2012 Jan; 44(1):128-33. PubMed ID: 22310596
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen.
    Meçule A, Tinti F, Bachetoni A, Poli L, D'Alessandro M, Alessandri C, Umbro I, Nofroni I, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2011 May; 43(4):1017-9. PubMed ID: 21620040
    [Abstract] [Full Text] [Related]

  • 13. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.
    Ruangkanchanasetr P, Sanohdontree N, Supaporn T, Sathavarodom N, Satirapoj B.
    Ann Transplant; 2016 Dec 16; 21():765-774. PubMed ID: 27980321
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience.
    Slatinska J, Rohal T, Wohlfahrtova M, Viklicky O.
    Transplant Proc; 2013 May 16; 45(4):1491-6. PubMed ID: 23726604
    [Abstract] [Full Text] [Related]

  • 15. Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience.
    Ogura Y, Imai H, Kamei H, Hori T, Kurata N, Onishi Y.
    Ann Transplant; 2016 Jul 19; 21():448-55. PubMed ID: 27432248
    [Abstract] [Full Text] [Related]

  • 16. Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients.
    Stifft F, Undre N, van Hooff JP, Christiaans MH.
    Ther Drug Monit; 2016 Aug 19; 38(4):456-62. PubMed ID: 27128604
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
    Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, Malvezzi P, Le Meur Y, Garrigue V, Del Bello A, Rostaing L.
    Adv Ther; 2019 Feb 19; 36(2):462-477. PubMed ID: 30552587
    [Abstract] [Full Text] [Related]

  • 18. Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients.
    Uchida J, Iwai T, Kabei K, Machida Y, Kuwabara N, Naganuma T, Kumada N, Nakatani T.
    Transplant Proc; 2014 Feb 19; 46(2):532-6. PubMed ID: 24656005
    [Abstract] [Full Text] [Related]

  • 19. Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients.
    Kannegieter NM, Shuker N, Vafadari R, Weimar W, Hesselink DA, Baan CC.
    Ther Drug Monit; 2016 Apr 19; 38(2):280-4. PubMed ID: 26606072
    [Abstract] [Full Text] [Related]

  • 20. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L, Bunnapradist S, Grinyó JM, Ciechanowski K, Denny JE, Silva HT, Budde K, Envarsus Study Group.
    Am J Kidney Dis; 2016 Apr 19; 67(4):648-59. PubMed ID: 26717860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.